Clinical Impact of Bacteriuria on Chronic Inflammation in Asymptomatic Hemodialysis Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01570556|
Recruitment Status : Unknown
Verified March 2012 by Assaf-Harofeh Medical Center.
Recruitment status was: Recruiting
First Posted : April 4, 2012
Last Update Posted : April 4, 2012
|Condition or disease||Intervention/treatment||Phase|
|Inflammation on Dialysis Bacteriuria in Hemodialysis Patients||Other: Antibiotic treatment||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||120 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Clinical Impact of Bacteriuria on Chronic Inflammation in Asymptomatic Hemodialysis Patients|
|Study Start Date :||December 2011|
|Estimated Primary Completion Date :||December 2013|
Active Comparator: Patients with positive culture, treatment group
These asymptomatic patients with positive urinary culture, seven days of antibiotics will be given according to the bacteriogram sensitivity.
Other: Antibiotic treatment
In patients with positive urinary culture, seven days of antibiotics will be given orally according to the bacteriogram sensitivity.
No Intervention: Patients with positive culture, observation only
These asymptomatic patients with positive urine culture, will be observed only during the study period.
- Change in serum inflammatory markers (CRP, IL-6) [ Time Frame: 3 months, 6 months, and 12 months ]
- Cardio-vascular events [ Time Frame: 3 months, 6 months and 12 months ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01570556
|Nephrology Department, Assaf Harofeh Medical Center||Recruiting|
|Zerifin, Israel, 70300|
|Contact: Ilia Beberashvili, MD 972577346133 firstname.lastname@example.org|
|Contact: Kobi Stav, MD 972527493007 email@example.com|
|Principal Investigator: Ilia Beberashvili, MD|